U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Iontotherapeutic device and process and iontotherapeutic unit dose

Patent 5042975 Issued on August 27, 1991. Estimated Expiration Date: Icon_subject August 27, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

3077884

3163166

Epidermal iontophoresis device
Patent #: 4141359
Issued on: 02/27/1979
Inventor: Jacobsen ,   et al.

Device for iontophoretic application of fluoride on tooth
Patent #: 4149533
Issued on: 04/17/1979
Inventor: Ishikawa ,   et al.

Iontophoretic electrode device, method and gel insert
Patent #: 4383529
Issued on: 05/17/1983
Inventor: Webster

System for demand-based adminstration of insulin
Patent #: 4403984
Issued on: 09/13/1983
Inventor: Ash ,   et al.

Shiftable planetary gear train
Patent #: 4462274
Issued on: 07/31/1984
Inventor: Reppert ,   et al.

Iontophoresis device
Patent #: 4474570
Issued on: 10/02/1984
Inventor: Ariura ,   et al.

Transdermal drug applicator
Patent #: 4708716
Issued on: 11/24/1987
Inventor: Sibalis

Iontophoresis device
Patent #: 4764164
Issued on: 08/16/1988
Inventor: Sasaki

More ...

Inventors

Application

No. 046984 filed on 05/07/1987

US Classes:

604/20, Infrared, visible light, ultraviolet, X-ray or electrical energy applied to body (e.g., iontophoresis, etc.)607/153Means for wetting applicator-body interface

Examiners

Primary: Cohen, Lee S.

Attorney, Agent or Firm

Foreign Patent References

  • 2502015 FR 09/13/1982
  • 936928 SU 06/13/1982
  • 1088730 SU 04/13/1985

International Class

A61N 001/30

Abstract

This invention relates to development of an iontotherapeutic device for regulated transdermal systemic administration of ionizable pharmaceutical compounds.It also provides an iontotherapeutic process for transdermal administration of ionized pharmaceuticals, particularly those which are otherwise transdermally absorbed to a small degree or not all, such as peptide pharmaceuticals, for example, insulins. The invention also relates to unit dose forms, for example, those in which an ionized pharmaceutical is dispersed in a hydrophilic polymer. The unit dose is adapted to be assembled as part of the pharmaceutical reservoir electrode, so that the ionized pharmaceutical will be delivered transdermally and then be absorbed systemically when the iontotherapeutic device is in operation.

Other References

  • Journal of Controlled Release, 4(1986) 79-85 Keiichiro Okabe et a
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$16.95more info
 
Sign InRegister
Username  
Password   
forgot password?